TherapeuticsMD
TXMD
TXMD
41 hedge funds and large institutions have $3.03M invested in TherapeuticsMD in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
5
Closed
4
Calls
$14K
Puts
$4K
Net Calls
+$10K
Net Calls Change
+$4K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$125K |
| 2 |
Renaissance Technologies
New York
|
+$9.37K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.16K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$976 |
| 5 |
Morgan Stanley
New York
|
+$576 |
Top Sellers
| 1 |
TC
Tejara Capital
London,
United Kingdom
|
-$5.84K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.44K |
| 3 |
CC
Clearline Capital
New York
|
-$1.2K |
| 4 |
CPA
Capital Performance Advisors
Walnut Creek,
California
|
-$996 |
| 5 |
PS
Principal Securities
Des Moines,
Iowa
|
-$209 |
